This volume investigates the critical role of biomarkers in advancing herbal drug discovery through the application of nanotechnological approaches. It explores research into phytoconstituents and their integration with nanomedicines to enhance healthcare outcomes, addressing the limitations of conventional treatments by leveraging the structural diversity of herbal compounds. The book details the identification and therapeutic potential of various herbal constituents, including terpenoids, fatty acids, flavonoids, and steroids, in managing diverse health conditions. Furthermore, it examines how these agents target specific biomarkers such as nitric oxide, cytokines, and NF-κβ to achieve therapeutic effects.

This book presents a focused exploration of the intersection between biomarkers, herbal medicine, and nanomedicine, likely appealing to researchers and practitioners in pharmacology and alternative medicine. The detailed examination of phytoconstituents and their targeted action on specific biomarkers suggests a text rich in scientific data and potential therapeutic strategies. Its approach to nanotechnological applications for healthcare benefits indicates a forward-looking perspective on drug development. The comprehensive scope, covering various disorders from arthritis to cancer, positions it as a valuable resource for understanding the emerging field of biomarker-driven herbal drug discovery.